Classifying recommendations for clinical practice guidelines

Classifying recommendations for clinical practice guidelines
复制标题

DOI:
10.1542/peds.2004-1260
复制
发表时间:
2004-09-01
期刊:
影响因子:
8
通讯作者:
Simpson, L
Simpson, L
中科院分区:
医学2区
文献类型:
--
作者:
Homer, CJ;Lannon, CM;Simpson, L

文献摘要

被引文献

相似文献

临床实践指南旨在通过减少不适当的变化、为患者提供最佳结果、最大限度地减少伤害和促进具有成本效益的实践来提高临床护理质量。该声明对美国儿科学会(AAP)临床实践指南建议进行了明确的分类,以促进指南制定者、实施者和其他指南知识使用者之间的沟通,提高一致性,方便用户理解。该声明描述了制定循证临床实践指南和相关政策的 3 个连续活动:1)确定支持拟议建议的总体证据质量; 2)评估实施建议时预期的利益和危害之间的平衡; 3) 指定推荐强度。单个策略可以报告为“强烈推荐”、“推荐”、“选项”或“不推荐”。使用此分类的目的是提高指南制定过​​程的一致性和透明度,促进对 AAP 临床实践指南的理解,并增强 AAP 临床实践指南的实用性和可信度。
Clinical practice guidelines are intended to improve the quality of clinical care by reducing inappropriate variations, producing optimal outcomes for patients, minimizing harm, and promoting cost-effective practices. This statement proposes an explicit classification of recommendations for clinical practice guidelines of the American Academy of Pediatrics (AAP) to promote communication among guideline developers, implementers, and other users of guideline knowledge, to improve consistency, and to facilitate user understanding. The statement describes 3 sequential activities in developing evidence-based clinical practice guidelines and related policies: 1) determination of the aggregate evidence quality in support of a proposed recommendation; 2) evaluation of the anticipated balance between benefits and harms when the recommendation is carried out; and 3) designation of recommendation strength. An individual policy can be reported as a "strong recommendation," " recommendation," " option," or " no recommendation." Use of this classification is intended to improve consistency and increase the transparency of the guideline-development process, facilitate understanding of AAP clinical practice guidelines, and enhance both the utility and credibility of AAP clinical practice guidelines.